TSBX

Turnstone Biologics Corp. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website urnstonebio.com
Employees(FY) 94
ISIN US90042W1009

Performance

-7.32%

1W

-5.0%

1M

+3.5%

3M

-16.35%

6M

+4.52%

YTD

-75.82%

1Y

Profile

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.

Advanced Technical Analysis

Technical Analysis of TSBX 2024-05-10

Overview:

In analyzing the technical indicators for TSBX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for informed decisio...

See more ...

Recent News & Updates

2024-05-13 09:53
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024(Investorplace)
2024-05-13 05:01
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights(Globenewswire)
2024-05-07 21:00
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference(Globenewswire)
2024-04-15 21:00
Turnstone Biologics Appoints William Waddill to its Board of Directors(Globenewswire)
2024-03-21 19:52
TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023(Investorplace)
2024-03-21 05:06
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights(Globenewswire)
2024-02-20 17:00
Turnstone Biologics to Participate in Upcoming Investor Conferences(Globenewswire)
2024-02-20 04:00
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.(Globenewswire)
2023-11-26 17:00
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference(Globenewswire)
2023-11-09 08:49
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights(Globenewswire)
2023-11-02 18:00
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting(Globenewswire)
2023-10-29 18:00
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber(Globenewswire)
2023-09-27 18:00
Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting(Globenewswire)
2023-09-01 05:57
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update(Yahoo Finance)
2023-08-14 08:41
Steven Cohen's Q2 2023 13F Filing Update: Top Trades and Portfolio Overview(Yahoo Finance)
2023-08-04 06:30
Apogee Therapeutics, Turnstone Biologics, and More Stocks See Action From Activist Investors(Yahoo Finance)
2023-07-27 07:01
Steven Cohen Acquires Stake in Turnstone Biologics Corp(Yahoo Finance)
2023-07-27 05:36
FMR LLC Acquires Significant Stake in Turnstone Biologics Corp(Yahoo Finance)
2023-07-20 14:15
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering(Yahoo Finance)

Page 1 of 1

previousnext